✦ LIBER ✦

Fenofibrate decreased the rate of angiographic progression of CAD in patients with type 2 diabetes mellitus: Pravastatin may have prevented the development of diabetes mellitus in men

✍ Scribed by Sarah E. Capes

Book ID: 117836383
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 237 KB
Volume: 5
Category: Article
ISSN: 1361-2611
DOI: 10.1054/ebcm.2001.0373

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of fenofibrate on renal function

Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

✍ T. M. E. Davis; R. Ting; J. D. Best; M. W. Donoghoe; P. L. Drury; D. R. Sullivan 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 320 KB

The Leu72Met polymorphism of theGHRLgene

The Leu72Met polymorphism of theGHRLgene prevents the development of diabetic nephropathy in Chinese patients with type 2 diabetes mellitus

✍ Zhuang, Langen; Li, Ming; Yu, Changhua; Li, Can; Zhao, Mingming; Lu, Ming; Zheng 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 262 KB

THE IMPORTANCE OF CALCULATING GLOMERULAR

THE IMPORTANCE OF CALCULATING GLOMERULAR FILTRATION RATE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

✍ Foivos-Evangelos Kakavitsas; Christina Bountouri; Vassilikos George; Aimilia Gra 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Pravastatin compared to bezafibrate in t

Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with Type 2 diabetes mellitus

✍ C. Rustemeijer; J. A. Schouten; H. J. Voerman; H. E. S. J. Hensgens; A. J. M. Do 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background Both HMG-CoA reductase inhibitors and ®bric acid derivates are used for the treatment of dyslipidemia in Type 2 diabetes patients. The aim of this study was to compare the lipid lowering effect of 40 mg pravastatin, a HMG-CoA reductase inhibitor, and 400 mg beza®brate, a ®bric acid deriva

The effect of interventions to prevent c

The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus

✍ Elbert S Huang; James B Meigs; Daniel E Singer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Risk Predictors of Lower-limb Amputation

Risk Predictors of Lower-limb Amputation in Patients with Type 2 Diabetes Mellitus in the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) Study

✍ K. Rajamani; L. Li; J. Best; M. Voysey; R. Ting; M. D’Emden; M. Laakso; J. Baker 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 85 KB